Global Neurovascular Devices

Neurovascular Devices Comprehensive Study by Type (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices, Neurothrombectomy Devices), Application (Hospitals, Clinics, Ambulatory Surgical Units), Technology (Carotid Artery Angioplasty, Embolization and Coiling, Neurothrombectomy, Supporting Technologies), Disease Pathology (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation and Fistulas, Other Disease pathology) Players and Region - Global Market Outlook to 2028

Neurovascular Devices Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 5.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Vascular structure of the nervous tissues and blood vessels are majorly affected in the patient who is suffering from a neurovascular disorder. This leads to moderate to severe damage to the brain resulting in a condition such as cerebral haemorrhage and strokes. According to the report, stroke is the third leading cause of disability and death worldwide. The neurovascular device is used to treat several neurovascular diseases that affect the central nervous system as well as the blood vascular system. Increase in geriatric population across the country and upsurge in the number of patient suffering from the neurovascular disorder is expected to increase the demand for neurovascular devices. As per WHO, the global geriatric population (aged 65 years and above) is expected to rise from 7% in 2000 to 16% in 2050.

The Global Neurovascular Devices market presents a comprehensive analysis of the Neurovascular Devices market by product type (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices and Neurothrombectomy Devices), by end-user/application (Hospitals, Clinics and Ambulatory Surgical Units), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. The key Players profiled in the report are Johnson & Johnson (United States), Terumo Corporation (Japan), Medtronic, Plc (United States), Abbott Laboratories (United States), Stryker Corporation (United States), Penumbra, Inc. (United States), W. L. Gore & Associates, Inc. (United States), Merit Medical Systems, Inc. (United States) and Microport Scientific Corporation (China).

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Key Companies ProfiledJohnson & Johnson (United States), Terumo Corporation (Japan), Medtronic, Plc (United States), Abbott Laboratories (United States), Stryker Corporation (United States), Penumbra, Inc. (United States), W. L. Gore & Associates, Inc. (United States), Merit Medical Systems, Inc. (United States) and Microport Scientific Corporation (China)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Advancement In The Manufacturing Process Of Neurovascular Devices

Market Growth Drivers:
Large Obese And Ageing Population, Constant Development In Ongoing Product and Favourable Medical Reimbursement

Challenges:
Lack Of Skilled Neurosurgeons

Restraints:
Stringent Government Regulation and High Cost Associated With Neurovascular Devices

Opportunities:
Research And Development In Field Of Neurovascular Devices, Growing Concern Among Neurosurgeons About Procedures And Devices and Growing Number Of Researches In The Field Of Neurovascular Therapies

Regional Breakdown and Segment Analysis
This section of our report presents a realistic picture of the Global Neurovascular Devices industry. Investors and manufacturers can easily understand the inherent opportunities and challenges for their products in the geographical region of interest. For instance, while the North America holds majority of market share of the Neurovascular Devices

The Technology, such as Carotid Artery Angioplasty, is boosting the Neurovascular Devices market and is anticipated to experience a steady growth during the forecast period.

The Disease Pathology, such as Ischemic Strokes, is boosting the Neurovascular Devices market and is anticipated to experience a steady growth during the forecast period.

The regional segmentation covered in this report are:
South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)

Report Objectives / Segmentation Covered

By Type
  • Aneurysm Coiling & Embolization Devices
  • Cerebral Balloon Angioplasty & Stenting Systems
  • Support Devices
  • Neurothrombectomy Devices
By Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Units
By Technology
  • Carotid Artery Angioplasty
  • Embolization and Coiling
  • Neurothrombectomy
  • Supporting Technologies

By Disease Pathology
  • Ischemic Strokes
  • Cerebral Aneurysms
  • Arteriovenous Malformation and Fistulas
  • Other Disease pathology

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Large Obese And Ageing Population
      • 3.2.2. Constant Development In Ongoing Product
      • 3.2.3. Favourable Medical Reimbursement
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Skilled Neurosurgeons
    • 3.4. Market Trends
      • 3.4.1. Advancement In The Manufacturing Process Of Neurovascular Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurovascular Devices, by Type, Application, Technology, Disease Pathology and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Neurovascular Devices (Value)
      • 5.2.1. Global Neurovascular Devices by: Type (Value)
        • 5.2.1.1. Aneurysm Coiling & Embolization Devices
        • 5.2.1.2. Cerebral Balloon Angioplasty & Stenting Systems
        • 5.2.1.3. Support Devices
        • 5.2.1.4. Neurothrombectomy Devices
      • 5.2.2. Global Neurovascular Devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Ambulatory Surgical Units
      • 5.2.3. Global Neurovascular Devices by: Technology (Value)
        • 5.2.3.1. Carotid Artery Angioplasty
        • 5.2.3.2. Embolization and Coiling
        • 5.2.3.3. Neurothrombectomy
        • 5.2.3.4. Supporting Technologies
      • 5.2.4. Global Neurovascular Devices by: Disease Pathology (Value)
        • 5.2.4.1. Ischemic Strokes
        • 5.2.4.2. Cerebral Aneurysms
        • 5.2.4.3. Arteriovenous Malformation and Fistulas
        • 5.2.4.4. Other Disease pathology
      • 5.2.5. Global Neurovascular Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Neurovascular Devices (Volume)
      • 5.3.1. Global Neurovascular Devices by: Type (Volume)
        • 5.3.1.1. Aneurysm Coiling & Embolization Devices
        • 5.3.1.2. Cerebral Balloon Angioplasty & Stenting Systems
        • 5.3.1.3. Support Devices
        • 5.3.1.4. Neurothrombectomy Devices
      • 5.3.2. Global Neurovascular Devices by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Ambulatory Surgical Units
      • 5.3.3. Global Neurovascular Devices by: Technology (Volume)
        • 5.3.3.1. Carotid Artery Angioplasty
        • 5.3.3.2. Embolization and Coiling
        • 5.3.3.3. Neurothrombectomy
        • 5.3.3.4. Supporting Technologies
      • 5.3.4. Global Neurovascular Devices by: Disease Pathology (Volume)
        • 5.3.4.1. Ischemic Strokes
        • 5.3.4.2. Cerebral Aneurysms
        • 5.3.4.3. Arteriovenous Malformation and Fistulas
        • 5.3.4.4. Other Disease pathology
      • 5.3.5. Global Neurovascular Devices Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Neurovascular Devices (Price)
      • 5.4.1. Global Neurovascular Devices by: Type (Price)
  • 6. Neurovascular Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Terumo Corporation (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic, Plc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Stryker Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Penumbra, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. W. L. Gore & Associates, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merit Medical Systems, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Microport Scientific Corporation (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Neurovascular Devices Sale, by Type, Application, Technology, Disease Pathology and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Neurovascular Devices (Value)
      • 7.2.1. Global Neurovascular Devices by: Type (Value)
        • 7.2.1.1. Aneurysm Coiling & Embolization Devices
        • 7.2.1.2. Cerebral Balloon Angioplasty & Stenting Systems
        • 7.2.1.3. Support Devices
        • 7.2.1.4. Neurothrombectomy Devices
      • 7.2.2. Global Neurovascular Devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Ambulatory Surgical Units
      • 7.2.3. Global Neurovascular Devices by: Technology (Value)
        • 7.2.3.1. Carotid Artery Angioplasty
        • 7.2.3.2. Embolization and Coiling
        • 7.2.3.3. Neurothrombectomy
        • 7.2.3.4. Supporting Technologies
      • 7.2.4. Global Neurovascular Devices by: Disease Pathology (Value)
        • 7.2.4.1. Ischemic Strokes
        • 7.2.4.2. Cerebral Aneurysms
        • 7.2.4.3. Arteriovenous Malformation and Fistulas
        • 7.2.4.4. Other Disease pathology
      • 7.2.5. Global Neurovascular Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Neurovascular Devices (Volume)
      • 7.3.1. Global Neurovascular Devices by: Type (Volume)
        • 7.3.1.1. Aneurysm Coiling & Embolization Devices
        • 7.3.1.2. Cerebral Balloon Angioplasty & Stenting Systems
        • 7.3.1.3. Support Devices
        • 7.3.1.4. Neurothrombectomy Devices
      • 7.3.2. Global Neurovascular Devices by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Ambulatory Surgical Units
      • 7.3.3. Global Neurovascular Devices by: Technology (Volume)
        • 7.3.3.1. Carotid Artery Angioplasty
        • 7.3.3.2. Embolization and Coiling
        • 7.3.3.3. Neurothrombectomy
        • 7.3.3.4. Supporting Technologies
      • 7.3.4. Global Neurovascular Devices by: Disease Pathology (Volume)
        • 7.3.4.1. Ischemic Strokes
        • 7.3.4.2. Cerebral Aneurysms
        • 7.3.4.3. Arteriovenous Malformation and Fistulas
        • 7.3.4.4. Other Disease pathology
      • 7.3.5. Global Neurovascular Devices Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Neurovascular Devices (Price)
      • 7.4.1. Global Neurovascular Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurovascular Devices: by Type(USD Million)
  • Table 2. Neurovascular Devices Aneurysm Coiling & Embolization Devices , by Region USD Million (2017-2022)
  • Table 3. Neurovascular Devices Cerebral Balloon Angioplasty & Stenting Systems , by Region USD Million (2017-2022)
  • Table 4. Neurovascular Devices Support Devices , by Region USD Million (2017-2022)
  • Table 5. Neurovascular Devices Neurothrombectomy Devices , by Region USD Million (2017-2022)
  • Table 6. Neurovascular Devices: by Application(USD Million)
  • Table 7. Neurovascular Devices Hospitals , by Region USD Million (2017-2022)
  • Table 8. Neurovascular Devices Clinics , by Region USD Million (2017-2022)
  • Table 9. Neurovascular Devices Ambulatory Surgical Units , by Region USD Million (2017-2022)
  • Table 10. Neurovascular Devices: by Technology(USD Million)
  • Table 11. Neurovascular Devices Carotid Artery Angioplasty , by Region USD Million (2017-2022)
  • Table 12. Neurovascular Devices Embolization and Coiling , by Region USD Million (2017-2022)
  • Table 13. Neurovascular Devices Neurothrombectomy , by Region USD Million (2017-2022)
  • Table 14. Neurovascular Devices Supporting Technologies , by Region USD Million (2017-2022)
  • Table 15. Neurovascular Devices: by Disease Pathology(USD Million)
  • Table 16. Neurovascular Devices Ischemic Strokes , by Region USD Million (2017-2022)
  • Table 17. Neurovascular Devices Cerebral Aneurysms , by Region USD Million (2017-2022)
  • Table 18. Neurovascular Devices Arteriovenous Malformation and Fistulas , by Region USD Million (2017-2022)
  • Table 19. Neurovascular Devices Other Disease pathology , by Region USD Million (2017-2022)
  • Table 20. South America Neurovascular Devices, by Country USD Million (2017-2022)
  • Table 21. South America Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 22. South America Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 23. South America Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 24. South America Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 25. Brazil Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 26. Brazil Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 27. Brazil Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 28. Brazil Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 29. Argentina Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 30. Argentina Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 31. Argentina Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 32. Argentina Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 33. Rest of South America Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 34. Rest of South America Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 35. Rest of South America Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 36. Rest of South America Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 37. Asia Pacific Neurovascular Devices, by Country USD Million (2017-2022)
  • Table 38. Asia Pacific Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 39. Asia Pacific Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 40. Asia Pacific Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 41. Asia Pacific Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 42. China Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 43. China Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 44. China Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 45. China Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 46. Japan Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 47. Japan Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 48. Japan Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 49. Japan Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 50. India Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 51. India Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 52. India Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 53. India Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 54. South Korea Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 55. South Korea Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 56. South Korea Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 57. South Korea Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 58. Taiwan Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 59. Taiwan Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 60. Taiwan Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 61. Taiwan Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 62. Australia Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 63. Australia Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 64. Australia Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 65. Australia Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 70. Europe Neurovascular Devices, by Country USD Million (2017-2022)
  • Table 71. Europe Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 72. Europe Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 73. Europe Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 74. Europe Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 75. Germany Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 76. Germany Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 77. Germany Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 78. Germany Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 79. France Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 80. France Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 81. France Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 82. France Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 83. Italy Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 84. Italy Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 85. Italy Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 86. Italy Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 87. United Kingdom Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 88. United Kingdom Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 89. United Kingdom Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 90. United Kingdom Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 91. Netherlands Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 92. Netherlands Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 93. Netherlands Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 94. Netherlands Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 95. Rest of Europe Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 96. Rest of Europe Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 97. Rest of Europe Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 98. Rest of Europe Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 99. MEA Neurovascular Devices, by Country USD Million (2017-2022)
  • Table 100. MEA Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 101. MEA Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 102. MEA Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 103. MEA Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 104. Middle East Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 105. Middle East Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 106. Middle East Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 107. Middle East Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 108. Africa Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 109. Africa Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 110. Africa Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 111. Africa Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 112. North America Neurovascular Devices, by Country USD Million (2017-2022)
  • Table 113. North America Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 114. North America Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 115. North America Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 116. North America Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 117. United States Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 118. United States Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 119. United States Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 120. United States Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 121. Canada Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 122. Canada Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 123. Canada Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 124. Canada Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 125. Mexico Neurovascular Devices, by Type USD Million (2017-2022)
  • Table 126. Mexico Neurovascular Devices, by Application USD Million (2017-2022)
  • Table 127. Mexico Neurovascular Devices, by Technology USD Million (2017-2022)
  • Table 128. Mexico Neurovascular Devices, by Disease Pathology USD Million (2017-2022)
  • Table 129. Neurovascular Devices Sales: by Type(K Units)
  • Table 130. Neurovascular Devices Sales Aneurysm Coiling & Embolization Devices , by Region K Units (2017-2022)
  • Table 131. Neurovascular Devices Sales Cerebral Balloon Angioplasty & Stenting Systems , by Region K Units (2017-2022)
  • Table 132. Neurovascular Devices Sales Support Devices , by Region K Units (2017-2022)
  • Table 133. Neurovascular Devices Sales Neurothrombectomy Devices , by Region K Units (2017-2022)
  • Table 134. Neurovascular Devices Sales: by Application(K Units)
  • Table 135. Neurovascular Devices Sales Hospitals , by Region K Units (2017-2022)
  • Table 136. Neurovascular Devices Sales Clinics , by Region K Units (2017-2022)
  • Table 137. Neurovascular Devices Sales Ambulatory Surgical Units , by Region K Units (2017-2022)
  • Table 138. Neurovascular Devices Sales: by Technology(K Units)
  • Table 139. Neurovascular Devices Sales Carotid Artery Angioplasty , by Region K Units (2017-2022)
  • Table 140. Neurovascular Devices Sales Embolization and Coiling , by Region K Units (2017-2022)
  • Table 141. Neurovascular Devices Sales Neurothrombectomy , by Region K Units (2017-2022)
  • Table 142. Neurovascular Devices Sales Supporting Technologies , by Region K Units (2017-2022)
  • Table 143. Neurovascular Devices Sales: by Disease Pathology(K Units)
  • Table 144. Neurovascular Devices Sales Ischemic Strokes , by Region K Units (2017-2022)
  • Table 145. Neurovascular Devices Sales Cerebral Aneurysms , by Region K Units (2017-2022)
  • Table 146. Neurovascular Devices Sales Arteriovenous Malformation and Fistulas , by Region K Units (2017-2022)
  • Table 147. Neurovascular Devices Sales Other Disease pathology , by Region K Units (2017-2022)
  • Table 148. South America Neurovascular Devices Sales, by Country K Units (2017-2022)
  • Table 149. South America Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 150. South America Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 151. South America Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 152. South America Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 153. Brazil Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 154. Brazil Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 155. Brazil Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 156. Brazil Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 157. Argentina Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 158. Argentina Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 159. Argentina Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 160. Argentina Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 161. Rest of South America Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 162. Rest of South America Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 163. Rest of South America Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 164. Rest of South America Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 165. Asia Pacific Neurovascular Devices Sales, by Country K Units (2017-2022)
  • Table 166. Asia Pacific Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 167. Asia Pacific Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 168. Asia Pacific Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 169. Asia Pacific Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 170. China Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 171. China Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 172. China Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 173. China Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 174. Japan Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 175. Japan Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 176. Japan Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 177. Japan Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 178. India Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 179. India Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 180. India Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 181. India Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 182. South Korea Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 183. South Korea Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 184. South Korea Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 185. South Korea Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 186. Taiwan Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 187. Taiwan Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 188. Taiwan Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 189. Taiwan Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 190. Australia Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 191. Australia Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 192. Australia Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 193. Australia Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 194. Rest of Asia-Pacific Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 195. Rest of Asia-Pacific Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 196. Rest of Asia-Pacific Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 197. Rest of Asia-Pacific Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 198. Europe Neurovascular Devices Sales, by Country K Units (2017-2022)
  • Table 199. Europe Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 200. Europe Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 201. Europe Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 202. Europe Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 203. Germany Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 204. Germany Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 205. Germany Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 206. Germany Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 207. France Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 208. France Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 209. France Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 210. France Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 211. Italy Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 212. Italy Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 213. Italy Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 214. Italy Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 215. United Kingdom Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 216. United Kingdom Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 217. United Kingdom Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 218. United Kingdom Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 219. Netherlands Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 220. Netherlands Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 221. Netherlands Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 222. Netherlands Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 223. Rest of Europe Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 224. Rest of Europe Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 225. Rest of Europe Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 226. Rest of Europe Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 227. MEA Neurovascular Devices Sales, by Country K Units (2017-2022)
  • Table 228. MEA Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 229. MEA Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 230. MEA Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 231. MEA Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 232. Middle East Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 233. Middle East Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 234. Middle East Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 235. Middle East Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 236. Africa Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 237. Africa Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 238. Africa Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 239. Africa Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 240. North America Neurovascular Devices Sales, by Country K Units (2017-2022)
  • Table 241. North America Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 242. North America Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 243. North America Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 244. North America Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 245. United States Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 246. United States Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 247. United States Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 248. United States Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 249. Canada Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 250. Canada Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 251. Canada Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 252. Canada Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 253. Mexico Neurovascular Devices Sales, by Type K Units (2017-2022)
  • Table 254. Mexico Neurovascular Devices Sales, by Application K Units (2017-2022)
  • Table 255. Mexico Neurovascular Devices Sales, by Technology K Units (2017-2022)
  • Table 256. Mexico Neurovascular Devices Sales, by Disease Pathology K Units (2017-2022)
  • Table 257. Neurovascular Devices: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Neurovascular Devices: by Type(USD Million)
  • Table 268. Neurovascular Devices Aneurysm Coiling & Embolization Devices , by Region USD Million (2023-2028)
  • Table 269. Neurovascular Devices Cerebral Balloon Angioplasty & Stenting Systems , by Region USD Million (2023-2028)
  • Table 270. Neurovascular Devices Support Devices , by Region USD Million (2023-2028)
  • Table 271. Neurovascular Devices Neurothrombectomy Devices , by Region USD Million (2023-2028)
  • Table 272. Neurovascular Devices: by Application(USD Million)
  • Table 273. Neurovascular Devices Hospitals , by Region USD Million (2023-2028)
  • Table 274. Neurovascular Devices Clinics , by Region USD Million (2023-2028)
  • Table 275. Neurovascular Devices Ambulatory Surgical Units , by Region USD Million (2023-2028)
  • Table 276. Neurovascular Devices: by Technology(USD Million)
  • Table 277. Neurovascular Devices Carotid Artery Angioplasty , by Region USD Million (2023-2028)
  • Table 278. Neurovascular Devices Embolization and Coiling , by Region USD Million (2023-2028)
  • Table 279. Neurovascular Devices Neurothrombectomy , by Region USD Million (2023-2028)
  • Table 280. Neurovascular Devices Supporting Technologies , by Region USD Million (2023-2028)
  • Table 281. Neurovascular Devices: by Disease Pathology(USD Million)
  • Table 282. Neurovascular Devices Ischemic Strokes , by Region USD Million (2023-2028)
  • Table 283. Neurovascular Devices Cerebral Aneurysms , by Region USD Million (2023-2028)
  • Table 284. Neurovascular Devices Arteriovenous Malformation and Fistulas , by Region USD Million (2023-2028)
  • Table 285. Neurovascular Devices Other Disease pathology , by Region USD Million (2023-2028)
  • Table 286. South America Neurovascular Devices, by Country USD Million (2023-2028)
  • Table 287. South America Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 288. South America Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 289. South America Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 290. South America Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 291. Brazil Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 292. Brazil Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 293. Brazil Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 294. Brazil Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 295. Argentina Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 296. Argentina Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 297. Argentina Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 298. Argentina Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 299. Rest of South America Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 300. Rest of South America Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 301. Rest of South America Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 302. Rest of South America Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 303. Asia Pacific Neurovascular Devices, by Country USD Million (2023-2028)
  • Table 304. Asia Pacific Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 305. Asia Pacific Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 306. Asia Pacific Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 307. Asia Pacific Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 308. China Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 309. China Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 310. China Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 311. China Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 312. Japan Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 313. Japan Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 314. Japan Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 315. Japan Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 316. India Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 317. India Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 318. India Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 319. India Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 320. South Korea Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 321. South Korea Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 322. South Korea Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 323. South Korea Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 324. Taiwan Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 325. Taiwan Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 326. Taiwan Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 327. Taiwan Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 328. Australia Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 329. Australia Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 330. Australia Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 331. Australia Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 332. Rest of Asia-Pacific Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 333. Rest of Asia-Pacific Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 334. Rest of Asia-Pacific Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 335. Rest of Asia-Pacific Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 336. Europe Neurovascular Devices, by Country USD Million (2023-2028)
  • Table 337. Europe Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 338. Europe Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 339. Europe Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 340. Europe Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 341. Germany Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 342. Germany Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 343. Germany Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 344. Germany Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 345. France Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 346. France Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 347. France Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 348. France Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 349. Italy Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 350. Italy Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 351. Italy Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 352. Italy Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 353. United Kingdom Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 354. United Kingdom Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 355. United Kingdom Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 356. United Kingdom Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 357. Netherlands Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 358. Netherlands Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 359. Netherlands Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 360. Netherlands Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 361. Rest of Europe Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 362. Rest of Europe Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 363. Rest of Europe Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 364. Rest of Europe Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 365. MEA Neurovascular Devices, by Country USD Million (2023-2028)
  • Table 366. MEA Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 367. MEA Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 368. MEA Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 369. MEA Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 370. Middle East Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 371. Middle East Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 372. Middle East Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 373. Middle East Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 374. Africa Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 375. Africa Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 376. Africa Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 377. Africa Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 378. North America Neurovascular Devices, by Country USD Million (2023-2028)
  • Table 379. North America Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 380. North America Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 381. North America Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 382. North America Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 383. United States Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 384. United States Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 385. United States Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 386. United States Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 387. Canada Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 388. Canada Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 389. Canada Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 390. Canada Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 391. Mexico Neurovascular Devices, by Type USD Million (2023-2028)
  • Table 392. Mexico Neurovascular Devices, by Application USD Million (2023-2028)
  • Table 393. Mexico Neurovascular Devices, by Technology USD Million (2023-2028)
  • Table 394. Mexico Neurovascular Devices, by Disease Pathology USD Million (2023-2028)
  • Table 395. Neurovascular Devices Sales: by Type(K Units)
  • Table 396. Neurovascular Devices Sales Aneurysm Coiling & Embolization Devices , by Region K Units (2023-2028)
  • Table 397. Neurovascular Devices Sales Cerebral Balloon Angioplasty & Stenting Systems , by Region K Units (2023-2028)
  • Table 398. Neurovascular Devices Sales Support Devices , by Region K Units (2023-2028)
  • Table 399. Neurovascular Devices Sales Neurothrombectomy Devices , by Region K Units (2023-2028)
  • Table 400. Neurovascular Devices Sales: by Application(K Units)
  • Table 401. Neurovascular Devices Sales Hospitals , by Region K Units (2023-2028)
  • Table 402. Neurovascular Devices Sales Clinics , by Region K Units (2023-2028)
  • Table 403. Neurovascular Devices Sales Ambulatory Surgical Units , by Region K Units (2023-2028)
  • Table 404. Neurovascular Devices Sales: by Technology(K Units)
  • Table 405. Neurovascular Devices Sales Carotid Artery Angioplasty , by Region K Units (2023-2028)
  • Table 406. Neurovascular Devices Sales Embolization and Coiling , by Region K Units (2023-2028)
  • Table 407. Neurovascular Devices Sales Neurothrombectomy , by Region K Units (2023-2028)
  • Table 408. Neurovascular Devices Sales Supporting Technologies , by Region K Units (2023-2028)
  • Table 409. Neurovascular Devices Sales: by Disease Pathology(K Units)
  • Table 410. Neurovascular Devices Sales Ischemic Strokes , by Region K Units (2023-2028)
  • Table 411. Neurovascular Devices Sales Cerebral Aneurysms , by Region K Units (2023-2028)
  • Table 412. Neurovascular Devices Sales Arteriovenous Malformation and Fistulas , by Region K Units (2023-2028)
  • Table 413. Neurovascular Devices Sales Other Disease pathology , by Region K Units (2023-2028)
  • Table 414. South America Neurovascular Devices Sales, by Country K Units (2023-2028)
  • Table 415. South America Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 416. South America Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 417. South America Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 418. South America Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 419. Brazil Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 420. Brazil Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 421. Brazil Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 422. Brazil Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 423. Argentina Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 424. Argentina Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 425. Argentina Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 426. Argentina Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 427. Rest of South America Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 428. Rest of South America Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 429. Rest of South America Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 430. Rest of South America Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 431. Asia Pacific Neurovascular Devices Sales, by Country K Units (2023-2028)
  • Table 432. Asia Pacific Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 433. Asia Pacific Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 434. Asia Pacific Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 435. Asia Pacific Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 436. China Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 437. China Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 438. China Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 439. China Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 440. Japan Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 441. Japan Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 442. Japan Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 443. Japan Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 444. India Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 445. India Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 446. India Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 447. India Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 448. South Korea Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 449. South Korea Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 450. South Korea Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 451. South Korea Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 452. Taiwan Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 453. Taiwan Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 454. Taiwan Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 455. Taiwan Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 456. Australia Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 457. Australia Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 458. Australia Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 459. Australia Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 460. Rest of Asia-Pacific Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 461. Rest of Asia-Pacific Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 462. Rest of Asia-Pacific Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 463. Rest of Asia-Pacific Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 464. Europe Neurovascular Devices Sales, by Country K Units (2023-2028)
  • Table 465. Europe Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 466. Europe Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 467. Europe Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 468. Europe Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 469. Germany Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 470. Germany Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 471. Germany Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 472. Germany Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 473. France Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 474. France Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 475. France Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 476. France Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 477. Italy Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 478. Italy Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 479. Italy Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 480. Italy Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 481. United Kingdom Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 482. United Kingdom Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 483. United Kingdom Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 484. United Kingdom Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 485. Netherlands Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 486. Netherlands Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 487. Netherlands Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 488. Netherlands Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 489. Rest of Europe Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 490. Rest of Europe Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 491. Rest of Europe Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 492. Rest of Europe Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 493. MEA Neurovascular Devices Sales, by Country K Units (2023-2028)
  • Table 494. MEA Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 495. MEA Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 496. MEA Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 497. MEA Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 498. Middle East Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 499. Middle East Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 500. Middle East Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 501. Middle East Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 502. Africa Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 503. Africa Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 504. Africa Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 505. Africa Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 506. North America Neurovascular Devices Sales, by Country K Units (2023-2028)
  • Table 507. North America Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 508. North America Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 509. North America Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 510. North America Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 511. United States Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 512. United States Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 513. United States Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 514. United States Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 515. Canada Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 516. Canada Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 517. Canada Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 518. Canada Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 519. Mexico Neurovascular Devices Sales, by Type K Units (2023-2028)
  • Table 520. Mexico Neurovascular Devices Sales, by Application K Units (2023-2028)
  • Table 521. Mexico Neurovascular Devices Sales, by Technology K Units (2023-2028)
  • Table 522. Mexico Neurovascular Devices Sales, by Disease Pathology K Units (2023-2028)
  • Table 523. Neurovascular Devices: by Type(USD/Units)
  • Table 524. Research Programs/Design for This Report
  • Table 525. Key Data Information from Secondary Sources
  • Table 526. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurovascular Devices: by Type USD Million (2017-2022)
  • Figure 5. Global Neurovascular Devices: by Application USD Million (2017-2022)
  • Figure 6. Global Neurovascular Devices: by Technology USD Million (2017-2022)
  • Figure 7. Global Neurovascular Devices: by Disease Pathology USD Million (2017-2022)
  • Figure 8. South America Neurovascular Devices Share (%), by Country
  • Figure 9. Asia Pacific Neurovascular Devices Share (%), by Country
  • Figure 10. Europe Neurovascular Devices Share (%), by Country
  • Figure 11. MEA Neurovascular Devices Share (%), by Country
  • Figure 12. North America Neurovascular Devices Share (%), by Country
  • Figure 13. Global Neurovascular Devices: by Type K Units (2017-2022)
  • Figure 14. Global Neurovascular Devices: by Application K Units (2017-2022)
  • Figure 15. Global Neurovascular Devices: by Technology K Units (2017-2022)
  • Figure 16. Global Neurovascular Devices: by Disease Pathology K Units (2017-2022)
  • Figure 17. South America Neurovascular Devices Share (%), by Country
  • Figure 18. Asia Pacific Neurovascular Devices Share (%), by Country
  • Figure 19. Europe Neurovascular Devices Share (%), by Country
  • Figure 20. MEA Neurovascular Devices Share (%), by Country
  • Figure 21. North America Neurovascular Devices Share (%), by Country
  • Figure 22. Global Neurovascular Devices: by Type USD/Units (2017-2022)
  • Figure 23. Global Neurovascular Devices share by Players 2022 (%)
  • Figure 24. Global Neurovascular Devices share by Players (Top 3) 2022(%)
  • Figure 25. Global Neurovascular Devices share by Players (Top 5) 2022(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 29. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Terumo Corporation (Japan) Revenue: by Geography 2022
  • Figure 31. Medtronic, Plc (United States) Revenue, Net Income and Gross profit
  • Figure 32. Medtronic, Plc (United States) Revenue: by Geography 2022
  • Figure 33. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 34. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 35. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Stryker Corporation (United States) Revenue: by Geography 2022
  • Figure 37. Penumbra, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Penumbra, Inc. (United States) Revenue: by Geography 2022
  • Figure 39. W. L. Gore & Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. W. L. Gore & Associates, Inc. (United States) Revenue: by Geography 2022
  • Figure 41. Merit Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Merit Medical Systems, Inc. (United States) Revenue: by Geography 2022
  • Figure 43. Microport Scientific Corporation (China) Revenue, Net Income and Gross profit
  • Figure 44. Microport Scientific Corporation (China) Revenue: by Geography 2022
  • Figure 45. Global Neurovascular Devices: by Type USD Million (2023-2028)
  • Figure 46. Global Neurovascular Devices: by Application USD Million (2023-2028)
  • Figure 47. Global Neurovascular Devices: by Technology USD Million (2023-2028)
  • Figure 48. Global Neurovascular Devices: by Disease Pathology USD Million (2023-2028)
  • Figure 49. South America Neurovascular Devices Share (%), by Country
  • Figure 50. Asia Pacific Neurovascular Devices Share (%), by Country
  • Figure 51. Europe Neurovascular Devices Share (%), by Country
  • Figure 52. MEA Neurovascular Devices Share (%), by Country
  • Figure 53. North America Neurovascular Devices Share (%), by Country
  • Figure 54. Global Neurovascular Devices: by Type K Units (2023-2028)
  • Figure 55. Global Neurovascular Devices: by Application K Units (2023-2028)
  • Figure 56. Global Neurovascular Devices: by Technology K Units (2023-2028)
  • Figure 57. Global Neurovascular Devices: by Disease Pathology K Units (2023-2028)
  • Figure 58. South America Neurovascular Devices Share (%), by Country
  • Figure 59. Asia Pacific Neurovascular Devices Share (%), by Country
  • Figure 60. Europe Neurovascular Devices Share (%), by Country
  • Figure 61. MEA Neurovascular Devices Share (%), by Country
  • Figure 62. North America Neurovascular Devices Share (%), by Country
  • Figure 63. Global Neurovascular Devices: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Johnson & Johnson (United States)
  • Terumo Corporation (Japan)
  • Medtronic, Plc (United States)
  • Abbott Laboratories (United States)
  • Stryker Corporation (United States)
  • Penumbra, Inc. (United States)
  • W. L. Gore & Associates, Inc. (United States)
  • Merit Medical Systems, Inc. (United States)
  • Microport Scientific Corporation (China)
Select User Access Type

Key Highlights of Report


Nov 2023 243 Pages 56 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neurovascular Devices Quantitative research analysis
Global Neurovascular Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Global Neurovascular Devices market is predicted to grow at a CAGR of 5.3% between 2022 - 2028.
Global Neurovascular Devices market is restrained by Stringent Government Regulation and High Cost Associated With Neurovascular Devices.
Hospitals is dominating end use application in Neurovascular Devices Market.
The Neurovascular Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.

Know More About Global Neurovascular Devices Report?

Have a Query? Click Here

Other Related Reports

Blood Glucose Test Strips Comprehensive Study by Application (Type 1 Diabetes, Type 2 Diabetes, Others), Technology (Glucose Oxidase, Glucose Dehydrogenase), Distribution Channel (Retail Pharmacy, Ho...
$ 3500
Vital Signs Monitoring Devices Comprehensive Study by Type (Blood Pressure Monitors (Mercury Blood Pressure Monitors, Sphygmomanometers, Digital Blood Pressure Monitors, Ambulatory Blood Pressure Mon...
$ 3750
Transfusion Disposable Products Comprehensive Study by Type (Disposabel Syringe, Infusion Bags, PVC Tube, Other), Application (Blood Disorders, Autoimmune Disorders, Cancer, Renal Disorders, Surgical...
$ 3450
Electric Dental Handpieces Comprehensive Study by Type (High-speed (air-turbine) handpiece, Low-speed (air-turbine) handpiece, Surgical handpieces, Endodontic handpieces, Implant handpieces.), Applic...
$ 3350
Nebulizers Comprehensive Study by Type (Jet or Pneumatic (Breath-Actuated, Vented), Ultrasonic (Portable, Stand Alone), Mesh (Static Mesh, Vibrating)), Application (Home, Hospitals and Clinics, Physi...
$ 3650
Thoracic Catheters Comprehensive Study by Type (Analog, Digital), Patient Type (Adults, Pediatric), Material (PVC Thoracic Catheters, HTS silicone thoracic catheters, XL silicone thoracic catheters)...
$ 3450